本レポートは、戦略担当者、マーケティング担当者、上級管理職が、COVID-19のシャットダウンからから脱却した世界のモノクローナル抗体（mAb）市場を評価するために必要な重要情報を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Monoclonal Antibodies (mAbs) - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Monoclonal Antibodies (mAbs) Market Definition And Segmentations
6.4 Market Segmentation By Source
6.4.1 Murine
6.4.2 Chimeric
6.4.3 Humanized
6.4.4 Human
6.5 Market Segmentation By Application
6.5.1 Anti-Cancer
6.5.2 Immunological
6.5.3 Infectious Disease
6.5.4 Hematological Disease
6.5.5 Other Applications
6.6 Market Segmentation By End-Users
6.6.1 Hospitals
6.6.2 Specialty Centers
6.6.3 Other End-Users
7 Major Market Trends
7.1 Investment in Targeted and Combination Therapy
7.2 Strategic Partnerships And Collaborations Among Market Players To Drive Innovation and Expansion In The Market
7.3 R&D Investments Revolutionizing Treatment
7.4 Integration of Artificial Intelligence for Accelerated Innovation
7.5 Product Innovation In Novel Therapies and Biosimilars Expands Treatment Options
8 Monoclonal Antibodies (mAbs) Market - Macro-Economic Scenario
8.1 COVID-19 Impact On The Monoclonal Antibodies (mAbs) Market
8.2 Impact Of The War In Ukraine On The Monoclonal Antibodies (mAbs) Market
8.3 Impact Of High Inflation On The Monoclonal Antibodies (mAbs) Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
9.2.1 Market Drivers 2018 - 2023
9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 - 2028
9.3.2 Market Restraints 2023 - 2028
10 Global Monoclonal Antibodies (mAbs) Market Segmentation
10.1 Global Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Monoclonal Antibodies (mAbs) Market, Regional and Country Analysis
11.1 Global Monoclonal Antibodies (mAbs) Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Monoclonal Antibodies (mAbs) Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Monoclonal Antibodies (mAbs) Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate tax structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Monoclonal Antibodies (mAbs) Market: Country Analysis
13.6 UK Market
13.7 UK Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Monoclonal Antibodies (mAbs) Market: Country Analysis
14.6 Russia Market
14.7 Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Monoclonal Antibodies (mAbs) Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Monoclonal Antibodies (mAbs) Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investment
18.1.12 Major Companies
18.2 Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Johnson & Johnson
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
nal overview
19.3 Merck & Co., Inc.
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 F. Hoffman-La Roche Ltd.
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Bristol Myers Squibb
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 GlaxoSmithKline plc
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial performance
20 Key Mergers And Acquisitions
20.1 Syngene Acquired Stelis Biopharma
20.2 Merck Acquired Prometheus Biosciences
20.3 Biocon Biologics Acquired Viatris Inc
20.4 Incyte Acquired Villaris Therapeutics
20.5 FUJIFILM Corporation Acquired Atara Biotherapeutics
20.6 Exelixis Inc. Acquired Gamamabs Pharma SA's AMHR2 Antibody Technology
20.7 Sanofi Acquired Kymab Group Ltd.
20.8 Boehringer Ingelheim Acquired Preclinical Antibody Pipeline From Northern Biologics Inc.
20.9 Servier Acquired Symphogen A/S
20.10 Gilead Sciences Acquired Forty Seven
20.11 True North Acquired Stake In Biocon Biologics
21 Pipeline Analysis
22 Opportunities And Strategies
22.1 Global Monoclonal Antibodies (mAbs) Market In 2028 - Countries Offering Most New Opportunities
22.2 Global Monoclonal Antibodies (mAbs) Market In 2028 - Segments Offering Most New Opportunities
22.3 Global Monoclonal Antibodies (mAbs) Market In 2028 - Growth Strategies
22.3.1 Market Trend Based Strategies
22.3.2 Competitor Strategies
23 Monoclonal Antibodies Market, Conclusions And Recommendations
23.1 Conclusions
23.2 Recommendations
23.2.1 Product
23.2.2 Place
23.2.3 Price
23.2.4 Promotion
23.2.5 People
24 Appendix
24.1 Geographies Covered
24.2 Market Data Sources
24.3 Research Methodology
24.4 Currencies
24.5 The Business Research Company
24.6 Copyright and Disclaimer
List of Tables
Table 1: Global Monoclonal Antibodies (mAbs) Market, Historic, 2018 - 2023, $ Million
Table 2: Global Monoclonal Antibodies (mAbs) Market, Forecast, 2023 - 2028, 2033F, $ Million
Table 3: Global Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 4: Global Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 5: Global Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 6: Global Monoclonal Antibodies (mAbs) Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 7: Global Monoclonal Antibodies (mAbs) Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
Table 9: Asia-Pacific Population, By Country, 2018-2028, Millions
Table 10: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 11: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 12: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 13: China GDP Per Capita, 2018-2023, $
Table 14: China Population, 2018-2028, Millions
Table 15: China Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 16: China Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 17: China Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 18: India Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 19: India Monoclonal antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 20: India Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 21: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 22: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 23: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 24: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 25: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 26: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 27: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 28: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 29: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 30: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 31: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 32: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $
Table 34: Western Europe Population, By Country, 2018-2028, Millions
Table 35: Western Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 36: Western Europe Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 37: Western Europe Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 38: UK Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 39: UK Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 40: UK Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 41: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 42: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 43: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 44: France Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 45: France Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 46: France Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 47: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 48: Eastern Europe Population, By Country, 2018-2028, Millions
Table 49: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 50: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 51: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 52: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 53: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 54: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 55: North America GDP Per Capita, By Country, 2018-2023, $
Table 56: North America Population, By Country, 2018-2028, Millions
Table 57: North America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 58: North America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 59: North America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 60: USA GDP Per Capita, 2018-2023, $
Table 61: USA Population, 2018-2028, Millions
Table 62: USA Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 63: USA Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 64: USA Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 65: South America GDP Per Capita, By Country, 2018-2023, $
Table 66: South America Population, By Country, 2018-2028, Millions
Table 67: South America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 68: South America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 69: South America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 70: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 71: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 72: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 73: Middle East GDP Per Capita, By Country, 2018-2023, $
Table 74: Middle East Population, By Country, 2018-2028, Millions
Table 75: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 76: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 77: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 78: Africa GDP Per Capita, By Country, 2018-2023, $
Table 79: Africa Population, By Country, 2018-2028, Millions
Table 80: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 81: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 82: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Table 83: Global Monoclonal Antibodies (mAbs) Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Table 84: Johnson & Johnson - Financial Overview, 2018 - 2022, $ Billion
Table 85: Merck & Co - Financial Overview, 2018 - 2022, $ Billion
Table 86: F. Hoffmann-La Roche Ltd - Financial Overview, 2018 - 2022, $ Billion
Table 87: Bristol-Myers Squibb - Financial Overview, 2018 - 2022, $ Billion
Table 88: GlaxoSmithKline plc - Financial Overview, 2018 - 2022, $ Billion
Table 89: Global Monoclonal Antibodies (MAbs) Market, Pipeline Analysis
Table 90: Global Monoclonal Antibodies (mAbs) Market Size Gain ($ Million), 2023 - 2028, By Country
Table 91: Global Monoclonal Antibodies (mAbs) Market Size Gain ($ Million), Segmentation By Source, 2023 - 2028
Table 92: Global Monoclonal Antibodies (mAbs) Market Size Gain ($ Million), Segmentation By Application, 2023 - 2028
Table 93: Global Monoclonal Antibodies (mAbs) Market Size Gain ($ Million), Segmentation By End-Users, 2023 - 2028
Table 94: Monoclonal Antibodies (mAbs) Market Data Sources
List of Figures
Figure 1: Global Monoclonal Antibodies (mAbs) Market Segmentation By Source
Figure 2: Global Monoclonal Antibodies (mAbs) Market Segmentation By Application
Figure 3: Global Monoclonal Antibodies (mAbs) Market Segmentation By End-Users
Figure 4: Global Monoclonal Antibodies (mAbs) Market, Historic, 2018 - 2023, $ Million
Figure 5: Global Monoclonal Antibodies (mAbs) Market, Forecast, 2023 - 2028, 2033F, $ Million
Figure 6: Global Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 7: Global Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 8: Global Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 9: Global Monoclonal Antibodies (mAbs) Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 10: Global Monoclonal Antibodies (mAbs) Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 11: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 12: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 13: Asia-Pacific Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 14: China Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 15: China Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 16: China Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 17: India Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 18: India Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 19: India Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 20: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 21: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 22: Japan Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 23: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 24: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 25: Australia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 26: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 27: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 28: Indonesia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 29: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 30: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 31: South Korea Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 32: Western Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 33: Western Europe Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 34: Western Europe Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 35: UK Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 36: UK Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 37: UK Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 38: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 39: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 40: Germany Monoclonal Antibodies (Mabs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 41: France Monoclonal Antibodies (Mabs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 42: France Monoclonal Antibodies (Mabs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 43: France Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 44: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 45: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 46: Eastern Europe Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 47: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 48: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 49: Russia Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 50: North America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 51: North America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 52: North America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 53: USA Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 54: USA Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 55: USA Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 56: South America Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 57: South America Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 58: South America Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 59: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 60: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 61: Brazil Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 62: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 63: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 64: Middle East Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 65: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 66: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 67: Africa Monoclonal Antibodies (mAbs) Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, $ Million
Figure 68: Global Monoclonal Antibodies (mAbs), Key Competitor Estimated Market Shares, 2022, Percentage (%)
Figure 69: Johnson & Johnson - Financial Overview, 2018 - 2022, $ Billion
Figure 70: Merck & Co - Financial Overview, 2018 - 2022, $ Billion
Figure 71: F. Hoffmann-La Roche Ltd - Financial Overview, 2018 - 2022, $ Billion
Figure 72: Bristol-Myers Squibb - Financial Overview, 2018 - 2022, $ Billion
Figure 73: GlaxoSmithKline plc - Financial Overview, 2018 - 2022, $ Billion
Figure 74: Geographic Regions Covered
